AKT inhibitors

Roche Abandons AKT Prostate Cancer Asset
BioSpace
Thu, 02/2/23 - 10:52 am
Roche
AKT inhibitors
Ipatasertib
clinical trials
castration-resistant prostate cancer
prostate cancer
Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers
Endpoints
Sun, 08/28/22 - 10:10 pm
Novartis
AKT inhibitors
Vaderis Therapeutics
Medicxi